miRNAs and epidermal langerhans cell development and function
miRNAs and epidermal langerhans cell development and function
批准号:
7979036
负责人:
QING-SHENG MI
金额:
$20.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-19 至 2012-05-31
关键词:
AffectAntigen PresentationAntigen-Presenting CellsAutoimmune DiseasesBone MarrowC-Type LectinsCell MaturationCell TherapyCellsCodeDendritic CellsDevelopmentDicer EnzymeEpidermisEquilibriumExhibitsFunctional RNAGene ExpressionGene Expression ProfileGene TargetingGenesGenetic TranslationGoalsHematopoietic stem cellsHomeostasisImmuneImmunityInfectionInterventionKnock-in MouseKnock-outKnowledgeLaboratoriesLangerhans cellLife Cycle StagesMalignant NeoplasmsMicroRNAsMolecularMolecular ProfilingMouse StrainsMusMutant Strains MicePathway interactionsPatternPlayPopulation HeterogeneityProcessProteinsRNARegulator GenesReportingReverse Transcriptase Polymerase Chain ReactionRibonuclease IIIRoleSkinSmall RNASorting - Cell MovementStem cellsT-LymphocyteTestingThymus GlandTimeTissuesTranslationsValidationbaseenhanced green fluorescent proteinhuman DICER1 proteinlangerinlymph nodesmacrophagemigrationmouse modelnovelpromoterprotein expressionpublic health relevance
中文摘要
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant):
Dendritic cells (DCs), a heterogeneous population originating from hematopoietic stem cells (HSCs) in the bone marrow (BM), are professional antigen-presenting cells that play key roles in determining the balance between immunity and tolerance induction. Langerhans cells (LCs) are skin-resident DCs that express the C-type lectin Langerin and have a life cycle distinct from many other types of DCs. Even though LCs were first described more than 100 years ago, their development and immunological functions still remain enigmatic. MicroRNAs (miRNAs), a class of 21-25 nt single-stranded non-coding small RNAs, are increasingly being recognized as important regulators of gene expression through the inhibition of effective mRNA translation. The ribonuclease III enzyme Dicer is required for the processing of mature and functional miRNAs. Using Cre-loxP tissue-specific Dicer deletion, our laboratory and others have reported that deletion of miRNAs in HSCs significantly affects the development and function of different immune cells. However, the role of miRNAs in the development of LCs is still currently unknown. To test the roles of miRNAs in the development of LCs, we generated a new mouse strain with tissue- specific disruption of Dicer in LCs using Langerin-Cre. Surprisingly, mice with miRNAs-deficiency in LCs had significantly reduced number of epidermal LCs and the expression of Langerin was significantly reduced in miRNA-deficient LCs. Furthermore, LCs have a specific miRNA gene expression profile compared to other immune cells. Thus, our central hypothesis is that miRNAs are very important components of the molecular circuitry that controls LC development and function. We will test our hypothesis by pursuing the following three Specific Aims: 1) To determine the expression patterns of miRNAs during LC maturation; 2) To investigate the role of miRNAs in LC development and function; 3) To identify the target genes of miRNAs involved in LC development. Our study will dramatically advance our knowledge on the molecular mechanisms underlying LC development and function, and may also facilitate the development of new intervention strategies for cancer, infectious and autoimmune diseases.
PUBLIC HEALTH RELEVANCE:
Langerhans cells (LCs) are skin-resident DCs that maintain skin homeostasis, but the detailed molecular pathways regulating LC development and function remain largely unknown. MicroRNAs (miRNAs) are a recently discovered class of evolutionarily conserved small non-coding RNAs that negatively regulate the expression of protein-coding genes. The overall goal of this proposal is to identify the LC-specific miRNA expression profile during development and define their function and direct targets. The results from the above pioneering studies may not only illuminate the new immunological and molecular mechanisms underlying LC development, but may also facilitate the development of new intervention strategies for related autoimmune diseases, infection, and cancer based on the LC cell therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Decoding TGF-beta signaling pathways in skin langerhans cells
-
批准号:10541915
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2022
-
负责人:QING-SHENG MI
-
依托单位:
microRNAs and NKT cell development and function
-
批准号:9241970
-
项目类别:
-
资助金额:$37.42万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function
-
批准号:9888305
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Serum miRNA Biomarkers of Islet Autoimmunity
-
批准号:9080976
-
项目类别:
-
资助金额:$77.37万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function
-
批准号:9222709
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Serum miRNA Biomarkers of Islet Autoimmunity
-
批准号:9248240
-
项目类别:
-
资助金额:$75.19万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in epidermal Langerhans cell ontogeny and function
-
批准号:9082306
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
microRNAs and NKT cell development and function
-
批准号:9098864
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2015
-
负责人:QING-SHENG MI
-
依托单位:
microRNA as biomarkers for the response to immunotherapy in melanoma
-
批准号:8383931
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2012
-
负责人:QING-SHENG MI
-
依托单位:
microRNA as biomarkers for the response to immunotherapy in melanoma
-
批准号:8549182
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2012
-
负责人:QING-SHENG MI
-
依托单位:
miRNAs and epidermal langerhans cell development and function
-
批准号:8131739
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2010
-
负责人:QING-SHENG MI
-
依托单位:
海外基金